You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nCoV

Showing 1 - 25 of 460
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Nanjing (Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac)

Active, not recruiting
  • COVID-19
  • Ad5-nCoV-IH
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Aug 12, 2022

Coronavirus Trial in Oxford (ChAdOx1 nCov-19)

Completed
  • Coronavirus
  • ChAdOx1 nCov-19
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Oct 21, 2022

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)

Not yet recruiting
  • COVID-19
  • Intramuscularly administered Ad5-nCoV vaccine
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 10, 2023

Epidemiologic, Clinical and Molecular Characteristics of Acute

Recruiting
  • Covid19
  • Patient with SAR-CoV-2 infection
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Oct 17, 2022

COVID-19 Trial in Lianyungang (batch 1 of Ad5-nCoV, batch 2 of Ad5-nCoV, batch 3 of Ad5-nCoV)

Completed
  • COVID-19
  • batch 1 of Ad5-nCoV
  • +2 more
  • Lianyungang, Jiangsu, China
    Guanyun Center for Disease Control and Prevention
Apr 5, 2022

COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)

Completed
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • Decatur, Georgia
  • +2 more
Jan 26, 2023

The Impact of nCoV-2019 on Children With Migraine

Completed
  • Migraine Disorders
  • COVID-19 Pandemic
  • questionnaires Only
  • Haifa, Israel
    Bnai Zion Medical Center
Oct 10, 2023

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Coronavirus Trial in United Kingdom (ChAdOx1 nCoV-19, MenACWY, ChAdOx1 nCoV-19 full boost)

Active, not recruiting
  • Coronavirus
  • ChAdOx1 nCoV-19
  • +8 more
  • Southampton, Hampshire, United Kingdom
  • +5 more
Jan 20, 2022

Covid19 Trial (DelNS1-2019-nCoV-RBD-OPT1, Matching )

Not yet recruiting
  • Covid19
  • DelNS1-2019-nCoV-RBD-OPT1
  • Matching placebo
  • (no location specified)
Jan 20, 2022

Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta

Active, not recruiting
  • ChAdOx1 nCoV-19 Vaccine
  • ChAdOx1 nCoV-19 vaccine
  • Assiut, Egypt
    Aliae AR Mohamed-Hussein
Sep 18, 2021

COVID-19 Trial in Entebbe (LNP-nCOV saRNA-02 Vaccine)

Recruiting
  • COVID-19
  • LNP-nCOV saRNA-02 Vaccine
  • Entebbe, Uganda
    MRC/UVRI & LSHTM Uganda Research Unit
Apr 14, 2022

COVID-19 Trial (Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH), Placebo)

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)
  • Placebo
  • (no location specified)
Nov 19, 2021

SARS-CoV-2 Trial in Vitória (Half dose of ChAdOx1 nCoV-19 (AZD1222), Standard dose of ChAdOx1 nCoV-19 (AZD1222))

Recruiting
  • SARS-CoV-2
  • Half dose of ChAdOx1 nCoV-19 (AZD1222)
  • Standard dose of ChAdOx1 nCoV-19 (AZD1222)
  • Vitória, Espirito Santo, Brazil
    Federal University of Espirito Santo
Sep 24, 2021

Coronavirus Trial in United Kingdom (ChAdOx1 nCoV-19 (Abs 260), MenACWY vaccine, ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR)

Active, not recruiting
  • Coronavirus
  • ChAdOx1 nCoV-19 (Abs 260)
  • +8 more
  • Southampton, Hampshire, United Kingdom
  • +19 more
Jan 20, 2022

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

Infection of Upper Respiratory Tract Caused by 2019-nCoV Trial in Shanghai (SA55 Injection)

Recruiting
  • Infection of Upper Respiratory Tract Caused by 2019-nCoV
  • SA55 Injection
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 12, 2023

Inactivated COVID-19 Vaccine in Thousands of Autoimmune Diseases

Recruiting
  • COVID-19 Vaccines
  • Autoimmune Diseases
  • the inactivated COVID-19 vaccines
  • Hangzhou, Zhejiang, China
    The Affiliated Hospital of Zhejiang Chinese Medicine University
Apr 25, 2023

Covid19 Trial in Hong Kong (DelNS1-nCoV-RBD LAIV, Matching )

Active, not recruiting
  • Covid19
  • DelNS1-nCoV-RBD LAIV
  • Matching placebo
  • Hong Kong, Hong Kong
    HKU Phase 1 Clinical Trials Centre
Sep 24, 2021

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial (Famotidine, Celecoxib, Placebo)

Not yet recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • (no location specified)
Aug 15, 2022

SARS-CoV-2 Infection Among Healthcare Workers

Recruiting
  • COVID-19
  • inactivated COVID-19 vaccines; orally aerosolized Ad5-nCoV
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Jan 10, 2023

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,

Active, not recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Miami, Florida
    US02-04: Integrated Health Solutions
Aug 15, 2022

SARS-CoV-2, Coronavirus, COVID-19 Trial in Pécs (Personalized health education, General health education)

Terminated
  • SARS-CoV-2
  • +4 more
  • Personalized health education
  • General health education
  • Pécs, Hungary
    Institute for Translational Medicine, University of Pécs
Jan 31, 2022

COVID-19 Trial in Gaborone (AZD 1222)

Completed
  • COVID-19
  • AZD 1222
  • Gaborone, Botswana
    Botswana Harvard Health Partnership
Feb 6, 2023